APA

Loi S., Sirtaine N., Piette F., Salgado R., Viale G., Van Eenoo F., Rouas G., Francis P., Crown J. P. A., Hitre E., de Azambuja E., Quinaux E., Di Leo A., Michiels S., Piccart M. J. & Sotiriou C. (20130412). Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chicago

Loi Sherene, Sirtaine Nicolas, Piette Fanny, Salgado Roberto, Viale Giuseppe, Van Eenoo Françoise, Rouas Ghizlane, Francis Prudence, Crown John P A, Hitre Erika, de Azambuja Evandro, Quinaux Emmanuel, Di Leo Angelo, Michiels Stefan, Piccart Martine J and Sotiriou Christos. 20130412. Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Harvard

Loi S., Sirtaine N., Piette F., Salgado R., Viale G., Van Eenoo F., Rouas G., Francis P., Crown J. P. A., Hitre E., de Azambuja E., Quinaux E., Di Leo A., Michiels S., Piccart M. J. and Sotiriou C. (20130412). Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

MLA

Loi Sherene, Sirtaine Nicolas, Piette Fanny, Salgado Roberto, Viale Giuseppe, Van Eenoo Françoise, Rouas Ghizlane, Francis Prudence, Crown John P A, Hitre Erika, de Azambuja Evandro, Quinaux Emmanuel, Di Leo Angelo, Michiels Stefan, Piccart Martine J and Sotiriou Christos. Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 20130412.